T. Rowe Price Associates’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $195M | Sell |
|
|||||
|
2023
Q4 | $150M | Sell |
|
|||||
|
2023
Q3 | $246M | Buy |
|
|||||
|
2023
Q2 | $311M | Sell |
|
|||||
|
2023
Q1 | $302M | Buy |
|
|||||
|
2022
Q4 | $208M | Sell |
|
|||||
|
2022
Q3 | $500M | Sell |
|
|||||
|
2022
Q2 | $615M | Buy |
|
|||||
|
2022
Q1 | $536M | Sell |
|
|||||
|
2021
Q4 | $549M | Sell |
|
|||||
|
2021
Q3 | $663M | Sell |
|
|||||
|
2021
Q2 | $625M | Sell |
|
|||||
|
2021
Q1 | $513M | Buy |
|
|||||
|
2020
Q4 | $257M | Buy |
|
|||||
|
2020
Q3 | $177M | Sell |
|
|||||
|
2020
Q2 | $122M | Sell |
|
|||||
|
2020
Q1 | $88.4M | Sell |
|
|||||
|
2019
Q4 | $177M | Buy |
|
|||||
|
2019
Q3 | $108M | Buy |
|
|||||
|
2019
Q2 | $114M | Buy |
|
|||||
|
2019
Q1 | $61.4M | Buy |
|